Kevin Quon
Kevin Quon
Stop FollowingKevin Quon
View as an RSS Feed
View Kevin Quon's Articles BY TICKER:
AAPL,
ADNC,
AGCO,
ALAN.OB,
ANGI,
ATVI,
AZO,
BBRY,
BBY,
BG,
BNNY,
CDXS,
CERE,
CLMS,
CRM,
CWH,
CZZ,
DFRG,
DRYS,
DVA,
ENOC,
FB,
FIVE,
FLCM,
FSLR,
FSYS,
GLW,
GOOG,
HL,
IMI,
IRWD,
KEG,
LPIH.OB,
MANU,
MCP,
MT,
NOW,
OPK,
PACB,
PACR,
PBI,
REGI,
RPAI,
SHLD,
STX,
SZYM,
TINY,
UNIS,
WFM,
WFR,
WFT,
WLT,
YELP,
ZNGA
- Rising Cocoa Bean Prices Find An Unlikely Hero In Algae
- 5 Oversold Industry Leaders Trading Below Book Value
- Power Struggle At CommonWealth REIT Highlights Undervalued Shares
- 5 Companies With Recent CEO Purchases Valued Over $250,000
-
Partners Embrace Win-Win Proposition In Solazyme's Tailored Oils
- Rising Stocks And The Wealthy Insiders Buying Them Up
- Rising Jet Fuel Costs Leave Airlines Looking For Answers
- Solazyme Looks To Asia And Beyond - An Interview With Solazyme's Director (Part 3)
- Opko Rises On Frost's Conviction Buy And Management Confidence
- Solazyme Addresses The Limitations Of Oil Production - An Interview With Solazyme's Director (Part 2)
- Solazyme Partners With Mitsui - An Interview With Solazyme's Business Development Director (Part 1)
- Opko's Frost Resumes His Purchases
- Opko Health's CEO Stops Buying Company Stock
- Now Is The Time To Buy Corning
- Are You Ready To Eat Algae? Solazyme Knows You Are
- 5 Companies For A Recession-Proof Growing Dividend Portfolio
- Insider Sales Suggest EnerNOC Is No Longer Undervalued
-
Coming To Terms With Solazyme's Delayed Dilution
- Short-Term Traders Sell As Solazyme Secures Its Future Growth
- Now Is The Time To Buy Unilife Corporation
- Opko's Frost: The CEO Who Keeps Buying His Company's Stock
- Is Pacific Biosciences A Possible Takeover Target?
- What New Co-Products Lie In Store For Solazyme?
- 5 Biotech Companies With Recent CEO Purchases
- Solazyme's Advantage In A Niche Field Of Heterotrophic Fermentation
- Insider Purchases Suggest Now Is The Time To Buy Weatherford
-
Are You Ready To Take Advantage Of Increased Volatility?
- Zynga: Now Is The Time To Reconsider This Social Media Stock
- 10 High-Yielding Dividends In Unique Industries
- These Innovative Biotech Stocks Are Beginning To Build Momentum
- 10 Recent CEO Insider Purchases To Consider
- Solazyme's Recent Scaling Accomplishment Is Bigger Than You Think
